DFM STUDENT SYLLABUS - Flipbook - Page 31
Multiple Sclerosis
456
Autoimmune Thyroid Diseases
456
Neurological Disorders
456
Cognitive Dysfunction
456
Neurodegenerative Conditions
456
Mood Disorders
456
Systemic Inflammatory Conditions
456
Chronic Fatigue Syndrome/ME
456
Fibromyalgia
457
Mast Cell Activation Syndrome
457
Barrier System Dysfunction
457
Leaky Gut Syndrome
457
Respiratory Conditions
457
Skin Disorders
457
Can Chemical Immune Reactivity Be Reversed?
457
Stage of Immune Dysregulation
457
Early-Stage Reactivity
457
Established Autoimmunity
458
Extent of Ongoing Exposure
458
Identifiable Discrete Exposures
458
Pervasive Multiple Exposures
458
Comprehensive Intervention Strategies
458
Exposure Reduction
458
Home Environment Modification
458
Workplace Modifications
459
Air and Water Filtration
459
Personal Care Product Modifications
459
Diet Optimization
459
Enhanced Detoxification Support
459
Glutathione Optimization
459
Liver Support
459
Sauna Therapy
459
Binders
459
30
